Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Fibroblast and immune cell interactions affect tissue repair and fibrosis.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Certain proteins are significantly increased in the skin of people with hidradenitis suppurativa.

Lysophosphatidic acid boosts stem cell growth and movement by creating reactive oxygen species.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Oleuropein increases IGF-1 levels in mouse skin.

Skin bacteria help in skin regeneration and wound healing, with a specific signal called IL-1β playing a crucial role.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Controlling Tslp can improve health in AEC syndrome patients.

SM04755 may be an effective topical treatment for psoriasis.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.